Graham Capital Management, L.P. Allakos Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Allakos Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 33,270 shares of ALLK stock, worth $18,631. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,270
Previous 38,259
13.04%
Holding current value
$18,631
Previous $48,000
31.25%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALLK
# of Institutions
104Shares Held
70.7MCall Options Held
43.8KPut Options Held
1.4K-
Bvf Inc San Francisco, CA16.6MShares$9.27 Million0.51% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$3.44 Million0.58% of portfolio
-
Deep Track Capital, LP Greenwich, CT5MShares$2.8 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$1.97 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.42MShares$1.92 Million0.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $47.4M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...